Atlas Trials

Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy Adult Subjects Under Fasting Conditions

Clinical trial NCT04038008 · COMPLETED

Trial details

NCT number
NCT04038008
Sponsor
Pharmtechnology LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2019-07-26
Primary completion
2019-09-17
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.